pharma · Cocaine-Related Disorders · Cocaine Dependence · DRUG
BRIGHT MINDS BIOSCIENCES
BRIGHT MINDS BIOSCIENCES INC.
BRIGHT MINDS BIOSCIENCES clinical programs — 393 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- 19 Vestry St, New York, NY 10013, US
- Employees
- 12
- Programs
- 1063
- Drugs
- 444
- Patents
- 57
BRIGHT MINDS BIOSCIENCES projects
393 ClinicalTrials.gov programs sponsored by BRIGHT MINDS BIOSCIENCES.
BRIGHT MINDS BIOSCIENCES has 393 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
sunitinib added to FOLFIRI
BRIGHT MINDS BIOSCIENCES INC.
Metastatic Colorectal Cancer
1 trial -
telephone based skills training intervention
BRIGHT MINDS BIOSCIENCES INC.
Smoking Cessation
1 trial -
topiramate
BRIGHT MINDS BIOSCIENCES INC.
Cocaine Dependence
1 trial -
tramadol
BRIGHT MINDS BIOSCIENCES INC.
Opioid Abuse
1 trial -
transdermal nicotine
BRIGHT MINDS BIOSCIENCES INC.
Cigarette Smoking
1 trial -
varenicline
BRIGHT MINDS BIOSCIENCES INC.
Alcoholism
1 trial -
widow spider antivenom
BRIGHT MINDS BIOSCIENCES INC.
Arachnidism
1 trial -
xue-fu-zhu-yu capsule
BRIGHT MINDS BIOSCIENCES INC.
Qi Stagnation and Blood Stasis Syndrome
1 trial -
zonisamide
BRIGHT MINDS BIOSCIENCES INC.
Nicotine Dependence
1 trial
Frequently asked questions
How many clinical projects does BRIGHT MINDS BIOSCIENCES have?
393 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.